Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
April 14, 2015
Patent Application Number
13626194
Date Filed
September 25, 2012
Patent Citations Received
Patent Primary Examiner
Patent abstract
The invention relates to the identification of fusion proteins comprising polypeptide and protein variants of fibroblast growth factor 21 (FGF21) with improved pharmaceutical properties. Also disclosed are methods for treating FGF21-associated disorders, including metabolic conditions.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
